Publications in International Scientific Journals(last two years)

2023
14. Yılmaz, D.; şenol, �.; Temiz reşitoğlu, M.; şahan fırat, S.; Tunçtan, B. . CELLULAR AND MOLECULAR BIOLOGY, 2023, 69, 15-23.
10.14715/cmb/2023.69.9.3

2022
13. Bahçeli, �.; şenol, �.; Temiz reşitoğlu, M.; Horat, F.; şahan fırat, S.; Tunçtan, B. . INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2022, 18, 1171-1188.
10.3923/ijp.2022.1171.1188

12. Temiz reşitoğlu, M. . JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 80, 276-293.
10.1097/FJC.0000000000001265

11. Temiz reşitoğlu, M.; Güden, D.; şenol, �.; Vezir, �.; Sucu, N.; Kibar, D.; Yılmaz, �.; Tunçtan, B.; Malık, K. . JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 79, 355-367.
10.1097/FJC.0000000000001187

10. Yorgancıoğlu, A.; Aksu, K.; Naycı, S.; Ediger, D. . BMC PULMONARY MEDICINE, 2022, 22, -.
10.1186/s12890-022-02008-9

9. Naycı, S. . TURKISH JOURNAL OF MEDICINE SCIENCE, 2022, , -.
10.55730/1300-0144.5321

2021
8. Cagli, A.; Senol, S.; Temiz‐resitoglu, M.; Guden, D.; Sari, A.; Sahan‐firat, S.; Tunctan, B. Soluble epoxide hydrolase inhibitor TPPU prevents hyperalgesia through regulating NLRC4 inflammasome‐related pro‐inflammatory and anti‐inflammatory signaling pathways in the lipopolysaccharide‐induced pain mouse model. WILEY, 2021, 0-0.
http://dx.doi.org/10.1002/ddr.21786

7. Temiz-resitoglu, M.; Guden, D.; Senol, S.; Vezir, O.; Sucu, N.; Kibar, D.; Yılmaz, S.; Tunctan, B.; Malik, K. Pharmacological inhibition of mTOR attenuates DOCA-salt-induced hypertension and related pathophysiology. OVID TECHNOLOGIES (WOLTERS KLUWER HEALTH), 2021, Publish Ahead of Print, 0-0.
http://dx.doi.org/10.1097/FJC.0000000000001187

6. Naycı, S. . RESPIRATORY MEDICINE, 2021, 183, 1-9.
10.1016/j.rmed.2021.106433.

5. Tiftik, R.; Temiz reşitoğlu, M.; Güden, D.; Bayrak, G.; ün, �.; Yılmaz, �.; şahan fırat, S. . CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2021, 99, 418-426.
10.1139/cjpp-2020-0305

4. şenol, �.; Temiz reşitoğlu, M.; Güden, D.; Sarı, A.; şahan fırat, S.; Tunçtan, B. . NEUROCHEMICAL RESEARCH, 2021, 46, 624-637.
10.1007/s11064-020-03197-7

3. Caglı, A.; şenol, �.; Temiz reşitoğlu, M.; Güden, D.; Sarı, A.; şahan fırat, S.; Tunçtan, B. . DRUG DEVELOPMENT RESEARCH, 2021, 82, 815-825.
10.1002/ddr.21786

2. Güden, D.; Temiz reşitoğlu, M.; şenol , �.; Kibar, D.; Yılmaz, �.; Tunçtan, B.; Malik, K.; şahan fırat, S. mTOR inhibition as a possible pharmacological target in the management of systemic inflammatory response and associated neuroinflammation by lipopolysaccharide challenge in rats. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2021, 99, 921-934.
10.1139/cjpp-2020-0487.

1. Cağli, A.; şenol, �.; Temiz reşitoğlu, M.; Güden, D.; Sarı, A.; şahan fırat, S.; Tunçtan, B. . DRUG DEVELOPMENT RESEARCH, 2021, , -.